University of Michigan (U-M) spinout company Courage Therapeutics has received a seed investment of up to $7.8 million from Arsenal Bridge Ventures.  The investment will enable Courage Therapeutics to complete essential testing and development to advance its drug candidates to clinical trials.   The company’s two drug development programmes aim to address obesity and restrictive eating […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!